🇺🇸 FDA
Patent

US 10869856

Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

granted A61KA61K31/40A61P

Quick answer

US patent 10869856 (Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/40, A61P, A61P31/18